Prospect Life Sciences
Jason Morton is an experienced executive in the medical device industry, currently serving as CEO and President of Prospect Life Sciences since 2016, where leadership focuses on consulting and contract services for medical device development and production. Morton has held various key positions, including Chief Operating Officer at Sharklet Technologies, Inc., where innovative technology for inhibiting bacterial growth was developed, and as Co-Founder of SinuTech, LLC, which specializes in improving surgical outcomes for chronic sinusitis patients. Additional roles include Director of Operations at Crosstrees Medical, Inc. and Manager of Product Development at Baxa Corporation. Morton holds an MBA from the University of Denver and a BS in Mechanical Engineering from Colorado State University.
This person is not in any teams
Prospect Life Sciences
We take pride in improving the performance and safety of new medical devices including sterile single use, electromechanical, combination and diagnostic kit products. PLS partners with medical innovators to: - create and ensure that consistent, repeatable, and reliable processes are in place for product manufacturability; - prove that the process is achieving performance and yielding expectations; - and ensure production scale up with relentless management of the supply chain and fulfillment process. From project management to supply chain management to QS management, at Prospect, we pay attention to details, and focus on manufacturing new medical devices with safety, cost efficiency, and scalability in mind.